NDC 61755-005
Eylea 40 mg per 1 mL injection, solution
On the label: Regeneron Pharmaceuticals, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Catalent Indiana, LLC | Bloomington, IN, United States | Makes it | Serious problems, FDA actionApr 24, 2026 · 10 inspections, 2 with FDA action |
| Regeneron Ireland Designated Activity Company | Limerick, Ireland | Makes it, makes the active ingredient and tests it | Problems found, fixed voluntarilyJun 13, 2025 · 2 inspections |
| Regeneron Pharmaceuticals, Inc. | Rensselaer, NY, United States | Makes it, makes the active ingredient and tests it | Problems found, fixed voluntarilyMar 22, 2024 · 10 inspections |
| Sharp Packaging Services, LLC | Allentown, PA, United States | Makes it, packages it and labels it | No problems foundNov 21, 2025 · 7 inspections |
| Simtra US LLC | Bloomington, IN, United States | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilySep 24, 2024 · 12 inspections |
| Vetter Pharma Fertigung GmbH & Co. KG (Langenargen Eisenbahnstrasse) | Langenargen, Germany | Makes it and tests it | Problems found, fixed voluntarilyMar 20, 2024 · 8 inspections |
| Bioreliance Corporation | Rockville, MD, United States | Tests it | Problems found, fixed voluntarilyJan 29, 2026 · 7 inspections |
| Bioreliance Ltd. | Glasgow Lanarkshire, United Kingdom | Tests it | Problems found, fixed voluntarilyMay 13, 2026 · 7 inspections |
| Eurofins Biopharma Product Testing Munich GmbH | Planegg, Germany | Tests it | Problems found, fixed voluntarilyJun 23, 2023 · 3 inspections |
| Eurofins Lancaster Laboratories, LLC | Lancaster, PA, United States | Tests it | Problems found, fixed voluntarilyAug 26, 2025 · 8 inspections |
| Nelson Laboratories, LLC | Salt Lake City, UT, United States | Tests it | Problems found, fixed voluntarilyJun 2, 2023 · 6 inspections |
| Packaging Coordinators, LLC | Philadelphia, PA, United States | Packages it and labels it | Problems found, fixed voluntarilyJan 31, 2025 · 6 inspections |
Recalls
- May 15, 2024 · Class II · Regeneron Pharmaceuticals Inc
Lack of Assurance of Sterility: Complaints of syringe breakage
Lots: Lot # 8231500321, Exp. date Oct-24 8231500335, Exp. date Jan-25 8231500333, Exp. date Jan-25 8231500334, Exp. date Jan-25 8231500339, Exp. date Jan-25 8231500347, Exp. date Jan-25 8231500336, Exp. date Jan-25 8231500337, Exp. date Jan-25 8231500340, Exp. date Jan-25 8268700014 (sample lot) exp. da… - Apr 23, 2024 · Class II · Regeneron Pharmaceuticals Inc
Lack of Assurance of Sterility: Complaints of syringe breakage
Lots: Lot # 8231500321, Exp 10/31 24; 8231500335, 8231500333, 8231500334, 8231500339, 8231500347, Exp 1/30/25
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Aflibercept: every company that makes it
- Form
- injection, solution, intravitreal
- Strength
- 40 mg per 1 mL
- Approval
- BLA BLA125387
- On the market since
- Nov 21, 2011
- Package NDCs
61755-005-0161755-005-0261755-005-5461755-005-55- Official label
- DailyMed (National Library of Medicine), updated Jul 7, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?